Verdict
The better option depends on the case, but the decision needs to stay traceable inside the case record.
The decision is capacity, margin, quality control, and risk. The case record should show why the choice was made.
The better option depends on the case, but the decision needs to stay traceable inside the case record.
Use this page as an operating summary, not a long essay.
A comparison should help production, not fill a page.
No long essay. Just the operational difference that matters inside a lab.
| Area | In-house milling vs outsourcing | TrazaLab | Edge |
|---|---|---|---|
| Decision | In-house milling vs outsourcing | TrazaLab keeps criteria, evidence, and approval inside the case. | Traceability |
| Files | Depends on the chosen workflow. | STL, DICOM, photos, PDFs, and notes stay attached. | TrazaLab |
| Risk | Usually experience-based. | Validation and rework signals appear before production. | TrazaLab |
| Learning | Hard to connect cause and cost. | Remakes are grouped by cause, doctor, material, and case. | TrazaLab |
This is the difference between tracking a remake and preventing one.
Keep the clinical facts, files, photos, Rx, notes, and decision context in one case record.
Check completeness, evidence, scan quality, clinical rules, and rework risk before production.
Use the comparison to make a production decision, not to create another disconnected article.
Tie the decision to the case timeline, doctor relationship, deadlines, files, and approvals.
Turn adjustments, delays, and remakes into measurable causes instead of repeat surprises.
A useful comparison should tell you when not to choose TrazaLab too.
Choose the production model that matches volume, cash, technician skill, and turnaround targets.
Choose TrazaLab to keep vendor files, approvals, remake causes, and case decisions visible.
Run one real case through TrazaLab and compare the difference before your team changes systems.